Regulation and Function of TMEM16F in Renal Podocytes

• Published in: International journal of molecular sciences 2018-06, Vol.19 (6), p.1798
• Main Authors: Schenk, Laura K, Ousingsawat, Jiraporn, Skryabin, Boris V, Schreiber, Rainer, Pavenstädt, Hermann, Kunzelmann, Karl
• Format: Article
• Language: English
• Subjects: Angiotensin; Angiotensin II; Apoptosis; Calcium (intracellular); Calcium currents; Calcium ions; Calcium signalling; Cell death; Cloning; Cytology; Defects; Diabetes mellitus; Diabetic nephropathy; Electrolytes; Electrolytic cells; Epithelial cells; Glomerulonephritis; Immune system; Intracellular; Intracellular signalling; Kidneys; Nephropathy; Phospholipids; Proteins; Proteinuria; Renal function; Rodents; T cell receptors; Urine
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms19061798

The Ca -activated phospholipid scramblase and ion channel TMEM16F is expressed in podocytes of renal glomeruli. Podocytes are specialized cells that form interdigitating foot processes as an essential component of the glomerular filter. These cells, which participate in generation of the primary urine, are often affected during primary glomerular diseases, such as glomerulonephritis and secondary hypertensive or diabetic nephropathy, which always leads to proteinuria. Because the function of podocytes is known to be controlled by intracellular Ca signaling, it is important to know about the role of Ca -activated TMEM16F in these cells. To that end, we generated an inducible TMEM16F knockdown in the podocyte cell line AB8, and produced a conditional mouse model with knockout of TMEM16F in podocytes and renal epithelial cells of the nephron. We found that knockdown of TMEM16F did not produce proteinuria or any obvious phenotypic changes. Knockdown of TMEM16F affected cell death of tubular epithelial cells but not of glomerular podocytes when analyzed in TUNEL assays. Surprisingly, and in contrast to other cell types, TMEM16F did not control intracellular Ca signaling and was not responsible for Ca -activated whole cell currents in podocytes. TMEM16F levels in podocytes were enhanced after inhibition of the endolysosomal pathway and after treatment with angiotensin II. Renal knockout of TMEM16F did not compromise renal morphology and serum electrolytes. Taken together, in contrast to other cell types, such as platelets, bone cells, and immune cells, TMEM16F shows little effect on basal properties of podocytes and does not appear to be essential for renal function.